Panel Discussion: Aligning Patient Experience with Next-Generation Brain Delivery for Less Burdensome, Safer & More Accessible Treatments

• Understanding patient and caregiver preferences on delivery route frequency and invasiveness to inform the design of brain shuttle and systemic platforms
• Evaluating tolerability safety perceptions and adherence challenges associated with next generation brain delivery approaches across real-world care settings
• Capturing patient perspectives on monitoring burden digital endpoints and treatment impact to guide clinically meaningful endpoint selection
• Identifying barriers to access and uptake of advanced CNS delivery technologies and defining strategies to ensure equitable and scalable implementation

Speakers:

Christopher Kadamus

Former Executive Director of Engineering, DDCS (Delivery, Device, & Connected Solutions)

Eli Lilly